Notifications

Recap

Ontario Today discusses anti-overdose drug for addicts

Ontario Today hosted a discussion about the controversial push to make Naloxone — a treatment for overdosing — more readily available for drug addicts. Here's a recap of the show and the live chat that followed.

Some medical professionals say Naloxone should be more readily available for addicts

Naloxone "is a safe, highly effective chemical compound that reverses the effects of opiates such as heroin," according to the Canadian Drug Policy Coalition's website.

Ontario Today hosted a discussion about the controversial push to make Naloxone — a treatment for overdosing — more readily available for drug addicts.

Dr. Meldon Kahan believes it should be easier for drug addicts to obtain Naloxone. (Meldon Kahan)
The show also discussed whether hard drugs, such as cocaine and heroin, can be done safely.

CBC Ottawa then hosted a live web chat on the subjects.

Ontario Today host Rita Celli's guest was Dr. Meldon Kahan, who works as an associate professor for the University of Toronto's family medicine department. He is also the Medical Director of the Substance Use Service at Women's College Hospital in Toronto and part of a working group calling on the Ministry of Health to create greater access to Naloxone.

In a 2013 report on Naloxone Kahan co-wrote for the Ontario Public Drug Program, an ad-hoc working group found that the drug is an "inexpensive and cost-effective strategy for reducing opioid overdose deaths in high-risk patients."

After the on-air chat, Kahan took part in the web chat, which can be reviewed below.

Comments

To encourage thoughtful and respectful conversations, first and last names will appear with each submission to CBC/Radio-Canada's online communities (except in children and youth-oriented communities). Pseudonyms will no longer be permitted.

By submitting a comment, you accept that CBC has the right to reproduce and publish that comment in whole or in part, in any manner CBC chooses. Please note that CBC does not endorse the opinions expressed in comments. Comments on this story are moderated according to our Submission Guidelines. Comments are welcome while open. We reserve the right to close comments at any time.